FDA Inspection
SSG VenturesSSG Ventures – FDA Inspection, Sep 30, 2021
Record Details
This FDA Inspection record concerns SSG Ventures, with an inspection on September 30, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- SSG Ventures
- Inspection Date
- September 30, 2021
- Product Type
- Drugs
View Company Profile
ID · 2231729a-6579-46f2-9f9c-aa2258e82360
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1153301
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
9- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.180(e)(1)Review of representative number of batches
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SSG Ventures
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 2, 2019 | Not classified | New York District Office | Drug Quality Assurance |
Other documents for SSG Ventures
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.